Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4101
Bright Minds Biosciences
DRUG
$226M
| $260K | ﹤0.01% |
3,612
+3,315
| +1,116% | +$260K |
2024 Q4
6 quarters
|
|
4102
Pulse Biosciences
PLSE
$3.81B
| $258K | ﹤0.01% |
9,310
+7,679
| +471% | +$181K |
2023 Q2
12 quarters
|
|
4103
Apex Treasury Corp Units
APXTU
| $258K | ﹤0.01% |
25,000
| – | – |
2025 Q4
2 quarters
|
|
4104
New Era Energy & Digital Inc
NUAI
$300M
| $255K | ﹤0.01% |
39,973
+16,789
| +72% | +$81.5K |
2025 Q3
3 quarters
|
|
4105
SandRidge Energy
SD
$498M
| $255K | ﹤0.01% |
18,583
+1,344
| +8% | +$20K |
2021 Q1
21 quarters
|
|
4106
Avidia Bancorp
AVBC
$409M
| $254K | ﹤0.01% |
12,106
-2,399
| -17% | -$47.9K |
2025 Q4
2 quarters
|
|
4107
iShares California Muni Bond ETF
CMF
$5.37B
| $254K | ﹤0.01% |
4,400
| – | – |
2014 Q3
47 quarters
|
|
4108
3D Systems Corp
DDD
$464M
| $253K | ﹤0.01% |
83,893
+77,297
| +1,172% | +$211K |
2013 Q2
52 quarters
|
|
4109
Forum Energy Technologies
FET
$920M
| $252K | ﹤0.01% |
5,016
-8,684
| -63% | -$484K |
2023 Q1
13 quarters
|
|
4110
Columbus McKinnon
CMCO
$528M
| $251K | ﹤0.01% |
16,621
+13,089
| +371% | +$195K |
2013 Q2
52 quarters
|
|
4111
Ultrapar
UGP
$6.03B
| $251K | ﹤0.01% |
49,986
+602
| +1% | +$3.31K |
2023 Q2
12 quarters
|
|
4112
SharonAI Holdings
SHAZ
$839M
| $251K | ﹤0.01% |
+2,959
| New | +$167K |
2026 Q2
0 quarters
|
|
4113
Honda
HMC
$44.4B
| $250K | ﹤0.01% |
9,229
+510
| +6% | +$13K |
2013 Q2
52 quarters
|
|
4114
Mesa Laboratories
MLAB
$703M
| $250K | ﹤0.01% |
2,510
+2,138
| +575% | +$215K |
2017 Q4
34 quarters
|
|
4115
Tradr 2X Long NVTS Daily ETF
NVTX
$20.8M
| $249K | ﹤0.01% |
+5,127
| New | +$393K |
2026 Q2
0 quarters
|
|
4116
Cytek Biosciences
CTKB
$784M
| $249K | ﹤0.01% |
56,130
+43,676
| +351% | +$186K |
2021 Q3
19 quarters
|
|
4117
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
| $248K | ﹤0.01% |
2,276
+2,274
| +113,700% | +$234K |
2025 Q4
2 quarters
|
|
4118
Sutro Biopharma
STRO
$158M
| $248K | ﹤0.01% |
7,456
-11,389
| -60% | -$355K |
2018 Q4
30 quarters
|
|
4119
Neurogene
NGNE
$544M
| $247K | ﹤0.01% |
7,868
+6,938
| +746% | +$191K |
2024 Q1
9 quarters
|
|
4120
Tiptree Inc
TIPT
$646M
| $247K | ﹤0.01% |
13,806
+9,070
| +192% | +$157K |
2014 Q2
48 quarters
|
|
4121
Ridgepost Capital
RPC
$1.04B
| $247K | ﹤0.01% |
31,339
+25,476
| +435% | +$203K |
2023 Q2
12 quarters
|
|
4122
Falcon's Beyond
FBYD
$341M
| $247K | ﹤0.01% |
13,758
+13,108
| +2,017% | +$186K |
2025 Q4
2 quarters
|
|
4123
Donegal Group Class A
DGICA
$690M
| $246K | ﹤0.01% |
13,020
+7,509
| +136% | +$130K |
2013 Q2
52 quarters
|
|
4124
AmpliTech
AMPG
$76.5M
| $245K | ﹤0.01% |
35,192
+34,618
| +6,031% | +$145K |
2026 Q1
1 quarter
|
|
4125
Commercial Bancgroup
CBK
$454M
| $244K | ﹤0.01% |
7,567
+5,923
| +360% | +$173K |
2025 Q4
2 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.